FDA Warns Against Foundayo Weight Loss Pill After Hospitalizations

FDA Warns Against Foundayo Weight Loss Pill After Hospitalizations...

The U.S. Food and Drug Administration (FDA) issued an urgent warning today about Foundayo, an over-the-counter weight loss supplement linked to severe health complications. At least 12 hospitalizations across seven states have been reported since March, with patients experiencing heart palpitations, kidney issues, and dangerously high blood pressure.

Foundayo surged in popularity earlier this year through TikTok influencers and targeted Facebook ads promising "rapid fat loss without dieting." The FDA's laboratory analysis confirmed the pills contain undisclosed prescription-strength stimulants, including a compound similar to amphetamines. This violates federal drug safety laws.

Major retailers including Amazon and Walmart have pulled Foundayo from shelves following the FDA alert. The agency advises consumers to immediately stop using the product and consult healthcare providers if experiencing dizziness, chest pain, or irregular heartbeat. No deaths have been reported, but three cases required intensive care.

This marks the seventh weight loss supplement warning from the FDA in 2026, reflecting growing concerns about unregulated products capitalizing on America's $78 billion diet industry. Searches for "Foundayo side effects" spiked 1,400% this morning as news spread.

Legal experts predict lawsuits against the Nevada-based distributor, NutraVita LLC, which has not responded to requests for comment. The company's website now displays a "temporarily unavailable" notice. State attorneys general in Texas and California have launched investigations.

Nutrition specialists remind consumers that no pill can replace medically supervised weight management. "When something sounds too good to be true, it almost always is," said Dr. Ellen Pritchard of the American Dietetic Association in a statement today.